OTX-2002
omega Theraputics
we re presenting preclinical data on our lead candidate, otx-2002, to regulate c-myc expression through epigenetic modulation in multiple hcc models at #wcgic2022 on june 30 at 09:30 a.m. and 05:15 p.m. cest. learn more &amp; see our poster here: 
Pioneering Epigenomic Programming. Omega Epigenomic Controllers: mRNA therapeutics as programmable epigenetic medicines #PrecisionGenomicControl